Celbrea


Developer of a prescription, point-of-care breast thermal screening test that uses single-use, skin-applied sensor pads to measure inter-breast surface temperature differences as a thermal biomarker. The test is positioned as a non‑invasive, non‑ionizing adjunct to established imaging pathways and is distributed via clinician prescription and a network of partner providers.

Industries

medical-device

Nr. of Employees

small (1-50)

Celbrea

2800 NW 105th Ave, Doral, FL 33172 USA


Products

Disposable breast thermal screening test

A prescription-only screening test consisting of single-use, skin-applied sensor pads that detect elevated skin temperature and report inter-breast temperature differences after a short application period to indicate need for further imaging.


Services

Coordination with partner physicians and clinicians to provide device access by prescription and integration into clinical evaluations; support for insurance or partner coverage where available.

Provision of web-based informational articles, screening guides, and resources about risk factors, screening guidelines, and access to services to support patient awareness and clinician communication.

Expertise Areas

  • Breast thermal biomarker screening
  • Point-of-care diagnostics
  • Non‑ionizing diagnostic methods
  • Clinical workflow integration and prescription-based deployment
  • Show More (4)

Key Technologies

  • Surface-temperature thermal sensing
  • Photochromic sensor arrays
  • High-density nano-sensor arrays
  • Single-use disposable adhesive sensor pads
  • Show More (2)

News & Updates

Article discussing equity, access barriers to screening and treatment, and the role of accessible screening technologies in underserved communities.

Summary of global breast cancer incidence and survival statistics and the importance of early detection.

Review of evidence linking body mass index and postmenopausal breast cancer risk and recommendations for weight management.

Discussion of regional disparities in access to cancer screening, barriers in rural and remote areas, and the role of mobile clinics, telemedicine, and portable diagnostics in improving access.

Device described on the site as cleared by the U.S. Food and Drug Administration as a Class I medical device.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.